North America accounts for the largest market share because of the high prevalence of chronic diseases like cancer which is a leading cause of lymphedema, and the increasing geriatric population in the region. It has been estimated that around 600,000 patients aged 65 or more are affected by venous ulcers. Moreover, secondary lymphedema affects approximately 1 in 1000 Americans every year. The high prevalence of these disorders fuels the growth of the compression therapy market in North America.
New Delhi, July 19, 2022 (GLOBE NEWSWIRE) -- The global compression therapy market gaining traction because of the driving factors such as increasing prevalence of vein disorders such as lymphedema, ulcers, varicose and spider veins, deep vein thrombosis, etc., along with the rising sport and other physical injury incidences…
A recent study conducted by the strategic consulting and market research firm, BlueWeave Consulting, revealed that the global compression therapy market was worth USD 3.4 billion in the year 2020. The data yielded by the study further reveals that the market is estimated to grow at the CAGR of 4.8%, earning revenue of around USD 4.7 billion by the end of 2027. The growth of the compression therapy market can be attributed to factors such as the increasing prevalence of chronic disorders like lymphedema and venous disorders. A second driving factor for the market is the use of compression therapy in the field of sports to treat injuries in athletes and to reduce pain. However, the availability of alternative treatment methods may hamper the market growth.
The Global Compression Therapy Market to Benefit fromthe Growing Use of Compression Garments
Many types of compression garments are available in the market, including compression stockings, compression bandages, and compression wraps. There are several applications for these during treatment and in everyday life as well as during physical activity. Compression garments have increased in popularity and are thus gaining great traction because they offer enhanced recovery during training sessions and assist in recovering from exercise-induced muscle damage.That is why these products are highly popular among athletes.
Varicose Vein Treatment Is Anticipated to Drive the Global Compression Therapy Market Growth in The Forecast Period
Based on applications, the global compression therapy market is segmented into lymphedema treatment, leg ulcer treatment, varicose vein treatment, and deep vein thrombosis treatment. Among these, the varicose vein treatment segment accounts for the largest market share. Varicose veins are estimated to affect 23% of American adults. About 22 million women and 11 million men between the ages of 40 and 80 are affected by this disease. Due to such a high prevalence of this disease, the demand for varicose vein treatment is rising at a high rate and also propelling the growth of the global compression therapy market.
Request For Free Sample Report @ https://www.blueweaveconsulting.com/report/global-compression-therapy-market/report-sample
Global Compression Therapy Market - By Distribution Channel
Based on distribution channels, the global compression therapy market is segmented into hospitals & clinics, pharmacies & retailers, and e-commerce platforms. Among all these segments, the hospitals & clinics segment holds the largest market share because of the large patient pool approaching hospitals for the treatment of various chronic diseases. Geriatric patients are more likely to suffer from leg ulcers and venous disorders and are often hospitalized for treatment. Compression therapy is therefore extremely reliable in hospitals since the therapy products are readily available.
Global Compression Therapy Market - Regional Insights
Geographically, the global compression therapy market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle-East & Africa. Among all the regions, North America held the largest market share in 2020. However, the Asia-Pacific region is projected to witness the highest CAGR during the forecast period. The market is gaining significant traction in this region mainly because of the high and increasing geriatric population. It has been estimated that the Asia-Pacific region will have around 226 million elderly people who are aged 65 or more by 2025. Furthermore, sports injuries will also likely spur the growth of the market in the Asia Pacific. Last but not least, the increasing prevalence of diseases like lymphedema is also boosting the compression therapy market in APAC countries.
Please Visit the Press Release of Global Compression Therapy Market: https://www.blueweaveconsulting.com/press-release/global-compression-therapy-market-growth-sturdy-at-4-8-cagr-projected-to-outstrip-usd-4-7-billion-by-the-end-of-2027
Impact of COVID-19 on Global Compression Therapy Market
Significant growth in the global compression therapy market was prompted by the COVID-19 pandemic.An elevated risk of venous thromboembolism is associated with COVID-19. Blood clotting causes have contributed to an increase in the prevalence of Deep Vein Thrombosis (DVT) as a result of the rising infection cases and hospitalization rates of COVID-19 cases.This is because patients with COVID-19 are advised to stay in bed for a long period of time, especially those who are 65 or older. Therefore, the compression therapy market grew during this period, which contributed to the growth of the overall global market.
The leading players in the global compression therapy market are OFA Bamberg, Bauerfeind AG, Thermotek, Inc., Tactile Medical, Sanyleg S.R.L., Medi Gmbh & Co. KG, Julius Zorn GmbH, Convatec Inc., Cardinal Health, Inc., BSN Medical, DJO Global, Inc., Gottfried Medical, Inc., Bio Compression Systems, Inc., Medline Industries, Inc., Arjohuntleigh, Medtronic PLC, 3M Company, Paul Hartmann AG, Smith & Nephew PLC, and other prominent players.
The industry participants focus on expanding their product portfolio through product approvals and launches. Several companies are partnering with sports teams as their official recovery partners and therapy partners to boost their brand awareness and expand their market revenue. Furthermore, the adoption of competitive strategies like mergers, acquisitions, and collaborations are also very prominent in this market.
Don’t miss the business opportunity of the global compression therapy market. Consult our analysts to gain crucial insights and facilitate your business growth.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of the global compression therapy market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends of the global compression therapy market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the growth drivers, challenges, and competitive dynamics of the market.
In May 2021, Koya Medical, a US-based medical technology manufacturer, announced to have received FDA 510(k) clearance for its active therapy system Dayspring for the treatment of lymphedema and venous diseases.
In May 2021, Boston Bruins, the Boston Ice Hockey team announced a partnership with Therabody, a US-based body wellness company, to become their official recovery partner and exclusive compression-therapy partner.
U.S, Canada, Germany, UK, France, Italy, Spain, Brazil, Mexico, Japan, South Korea, China, India, UAE, South Africa, Saudi Arabia
By Technique, By Product, By Application, By Distribution Channel, By Region
OFA Bamberg, Bauerfeind AG, Thermotek, Inc., Tactile Medical, Sanyleg S.R.L., Medi Gmbh& Co. KG, Julius Zorn GmbH, Convatec Inc., Cardinal Health, Inc., BSN Medical, DJO Global, Inc., Gottfried Medical, Inc., Bio Compression Systems, Inc., Medline Industries, Inc., Arjohuntleigh, Medtronic PLC, 3M Company, Paul Hartmann AG, Smith & Nephew PLC, and other prominent players.
Please Find Below Some Related Topics:
Anticancer Drugs Market- Global Industry Size, Share, Trend Analysis and Forecast Report, 2018-2028
India Pulse Oximeters Market- Size, Share, Trend Analysis and Forecast Report, 2018-2028
Dental Crowns and Bridges Market- Global Industry Size, Share, Trend Analysis and Forecast Report, 2018-2028
Fiducial Markers Market- Global Industry Size, Share, Trend Analysis and Forecast Report, 2018-2028
Surgical Retractor Market- Global Industry Size, Share, Trend Analysis and Forecast Report, 2018-2028
India Generic Drugs Market- Size, Share, Trend Analysis and Forecast Report, 2018-2028
BlueWeave Consulting provides comprehensive Market Intelligence (MI) Solutions to businesses regarding various products and services online and offline. We offer all-inclusive market research reports by analyzing both qualitative and quantitative data to boost up the performance of your business solutions. BWC has built its reputation from the scratch by delivering quality inputs and nourishing long-lasting relationships with its clients. We are a promising digital MI solutions company providing agile assistance to make your business endeavors successful.
BlueWeave Consulting & Research Pvt. Ltd
info@blueweaveconsulting.com https://www.blueweaveconsulting.com/
https://www.linkedin.com/company/blueweaveconsulting/
Verizon stock is moving lower after an earnings miss and dip in wireless subscriber growth.
Snap Inc. has never been an investor-friendly company as long as those investors weren't their founders, and the parent company of the Snapchat app made that even clearer Thursday.
Snap's 40% stock price crash on Friday after a dismal second quarter earnings report and brutal call is well warranted, one analysts explained to Yahoo Finance.
Verizon is set for its worst week since October 2008, but it's sitting on must-hold support right now.
Yahoo Finance Editor-in-Chief Andy Serwer discusses Berkshire's stake in Occidental Petroleum and what that indicates to investors.
U.S. stocks were under pressure Friday afternoon as a disastrous quarter from Snap weighed on the broader tech sector.
Fed’s zigzagging policies could ultimately lead to an outcome similar to what happened in its fight against inflation four decades ago.
Every one of those quarterly reports has shown a growing company, despite plenty of ups and downs in the economy—and the internet. Amazon’s worst quarter came in September 2001, when the internet bubble was blowing apart. Now, though, Amazon’s streak may be coming to an end.
Just where is the stock market going, that’s the question investors are trying to answer. The answer isn’t fully clear, though; markets have fallen for most of this year, but the last few days have seen the best trading in weeks. The problem is, investors and economists aren’t sure if we’re at a true bottom or just in the midst of a bear market rally. What happens next is anyone’s guess, but the history of bears and rallies can offer some suggestions. Looking back to the end of the Second World
Cleveland-Cliffs (CLF) delivered earnings and revenue surprises of -2.24% and 4.23%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
The Dow Jones fought back. Tesla stock rocketed after Elon Musk gave an update on its "best product ever." Apple stock popped. Bitcoin fell.
Every investor – from the most experienced legends of Wall Street to the most amateur of retail traders – keeps a close eye on the market, looking for some sign or signal to indicate just the right trades. Following the corporate insiders is one way to find an advantage. These are the company officers whose positions put them ‘in-the-know’ on their companies’ inner workings. That knowledge gives these bigwigs an inside track when it comes to trading their own stocks – and to keep the trading flo
The market rally had a strong week despite Friday's losses. Apple leads huge earnings with another big Fed rate hike due.
Rivian Automotive (NASDAQ: RIVN) was one of the hottest electric vehicle stocks of 2021. The EV maker went public at $78 per share last November, and its stock started trading at $106.75 before skyrocketing to an all-time high of $172.01 a week later. Rivian initially attracted so much attention because it was backed by Amazon (NASDAQ: AMZN) and Ford (NYSE: F).
(Bloomberg) -- Even for Alphabet Inc., financial gimmickry is no match for the power of the bear market.Most Read from BloombergThree Arrows Founders Break Silence Over Collapse of Crypto Hedge FundTrump Insiders Recall How He Spurned Pleas to Act as Riot RagedAmericans Who Can’t Afford Homes Are Moving to Europe InsteadMusk Lieutenant Scrutinized in Internal Tesla Purchasing ProbeBannon Found Guilty of Contempt for Defying Jan. 6 SubpoenaThe Google parent’s shares sank 2.5% on Monday, the first
When Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) CEO Warren Buffett speaks, Wall Street pays close attention. The easiest way for investors to monitor what Warren Buffett has been buying and selling is to track Berkshire Hathaway's quarterly 13F filings with the Securities and Exchange Commission (SEC).
GlaxoSmithKline (GSK) closed at $42.29 in the latest trading session, marking a +0.09% move from the prior day.
(Bloomberg) -- Verizon Communications Inc. shares plunged to their biggest drop in 14 years after the mobile-phone company cut its forecast for the second straight quarter, adding to concerns that consumers are pulling back on spending.Most Read from BloombergThree Arrows Founders Break Silence Over Collapse of Crypto Hedge FundTrump Insiders Recall How He Spurned Pleas to Act as Riot RagedAmericans Who Can’t Afford Homes Are Moving to Europe InsteadMusk Lieutenant Scrutinized in Internal Tesla
IBM (IBM) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
In this article, we discuss the 10 stocks to buy before their earnings reports. If you want to read about some more stocks expected to gain following their quarterly results, go directly to 5 Stocks to Buy Before Their Earnings Reports. With the inflation in the US at a 40-year high and the Federal Reserve […]